|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| 3rd Conference on Hyperhomocysteinemia, Saarbruecken/Germany | ||||||||||||||||
| August 21, 2002 | ||||||||||||||||
|
Central Laboratory - Saarland Medical School, Saarbruecken/Germany 11th and 12th April 2003 Friday, 11.04.2003 Session 1: Introduction, Epidemiology and Clinical Studies W. Herrmann – Principles of homocysteine metabolism in health and disease (D) I. Graham – Homocysteine in the context of the total risk (IR) J.D. Spence – Reduction of carotid plaque area by homocysteine lowering therapy (CN) C.D. Stehouwer – Association of blood pressure and hyperhomocysteinemia (NL) Session 2: Hyperhomocysteinemia – Associations with Folate, Cancer and Endothelial Dysfunction O. Stanger – Physiology of folic acid in health and disease (A) I.F. McDowell – Folic acid improves endothelial function in CAD (UK) J.M. Scott – The role of B-vitamins in reducing the risk for vascular disease (IR) B. Fowler – Folate and the risk of cancer (CH) Session 3: Associations of Hyperhomocysteinemia with Age and Neurodegenerative Diseases P.M. Ueland – Hyperhomocysteinemia and B-vitamin deficiencies from infancy to adolescence (NO) P.A. Wolf – Associations of hyperhomocysteinemia with dementia and Alzheimer's disease (USA) A. McCaddon – Homocysteine and cognitive decline in healthy elderly (UK) G. Scalabrino – Neurotropic action of vitamin B-12 (IT) S.J. Duthie – Homocysteine, B vitamins, and cognitive function in the elderly (UK) Session 4: The Role of Oxidative Stress in Hyperhomocysteinemia H. Jakubowski – homocysteine thiolactone: implications for atherosclerosis (USA) J.C. Chambers – Relationship between oxidative state of homocysteine and endothelial dysfunction (UK) N. Weiss – Influence of hyperhomocysteinemia on the cellular redox state (D) D. Fuchs – Moderate hyperhomocysteinemia and oxidative stress (A) Saturday, 12.04.2003 Session 5: Hyperhomocysteinemia in Women and Impaired Pregnancy S.F. Daly – Elevated homocysteine in early pregnancy: risk factor for severe preeclampsia (IR) H.J. Blom – Association of homocysteine and B-vitamins with the risk of neural tube defects (NL) V. De Leo – Effects of hormone replacement therapy on the homocysteine concentration in women (IT) K. Pietrzik – MTHFR modulates homocysteine reduction by folate treatment in women (D) Session 6: Diet and Genetics in Hyperhomocysteinemia J. Geisel – The role of genetic factors in the development of hyperhomocysteinemia (D) J.L. Gueant – Increased homocysteine and genetic determinants of B12 metabolism in neurological disorders (F) J. Dierkes – Nutritional and genetic factors are determinants of homocysteine concentration (D) A. Rydlewicz – The effect of folic acid supplementation on plasma homocysteine in an elderly population (UK) Session 7: Associations of Thrombosis and Renal Disease with Hyperhomocysteinemia M. den Heijer – Interaction of factor V Leiden and homocysteine as risk factor for deep vein thrombosis (NL) M. Cattaneo – Interrelations of B-vitamins and deep vein thrombosis (IT) I. Quéré – Methylfolate and homocysteine as risk factors for venous thromboembolism (F) C. van Guldener – Association of homocysteine and methionine metabolism with ESRD (NL) G. Sunder-Plassmann – Treatment of hyperhomocysteinemia in ESRD (A) Session 8: New Markers M.C. Stühlinger – Homocysteine impairs the NOS pathway: role of ADMA (A) R.H. Böger – Association of ADMA and endothelial dysfunction (D) M. Naruszewicz – Effect of homocysteine on CD-36 expression in humans (PL) E. Nexo – Holo-transcobalamin quantification: a new approach for the detection of vitamin B12 deficiency (NO) |
||||||||||||||||
| Organized by: | Prof. Dr. W. Herrmann | |||||||||||||||
| Invited Speakers: | see Programm | |||||||||||||||
| Deadline for Abstracts: | 29th November 2002 for poster abstracts | |||||||||||||||
| Registration: | Registration fee is 150 Euro (capacity limited to 200 participants) Registration deadline is 31st January 2003 Registration online and information at http://www.uniklinik-saarland.de/zentrallabor/homocysteine-conference.html Poster abstracts may be submitted. The Organizing Committee will select which posters will be displayed after reviewing the abstract. |
|||||||||||||||
| E-mail: | kchmdru@uniklinik-saarland.de | |||||||||||||||
| Posted by: | J. P. Knapp | |||||||||||||||
| Host: | proxy2.med-fddi.uni-sb.de | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||